Michal Galek-Aldridge | Health Sciences | Best Scholar Award

Published on by Research Awards

Mr. Michal Galek-Aldridge | Health Sciences | Best Scholar Award

University Medical Center Utrecht | Netherland

Michał Gałek-Aldridge is a multilingual medical researcher and physician with a strong interdisciplinary background bridging molecular science, engineering, and regenerative medicine. Born on September 18, 1993, in Tucson, Arizona, he holds Polish nationality and is fluent in English, Dutch, Polish, and Russian, with advanced proficiency in French and beginner-level Portuguese. Michał’s academic journey spans multiple international institutions, including The British School of Warsaw, the Anglo-American School in Moscow, and the International School of Amsterdam, culminating in an International Baccalaureate (IB) bilingual diploma in 2011. He pursued a Bachelor of Science in Molecular Science and Technology at Delft University of Technology and Leiden University, completing his thesis on “The loading of chemotherapeutics in polymersome carriers” at the Reactor Institute Delft. During this period, Michał received an Erasmus Mundus scholarship to study at Chalmers University in Sweden, where he expanded his expertise in nuclear chemistry, project management, waste management, and ecology. Driven by a passion for medicine, he subsequently earned both a Bachelor and Master of Science in Medicine at the University of Amsterdam, with clinical experience in orthopedic surgery at the UMC Amsterdam. Since 2021, Michał has been a PhD candidate at the University Medical Center Utrecht, focusing on the translation of regenerative surgical shoulder implants into clinical practice. His research integrates advanced therapies, 3D-printed medical devices, and regenerative medicine, while also addressing regulatory compliance, intellectual property assessment, and GMP evaluation for ATMP production. He actively supervises students at the 3D Lab, contributing to both academic and translational research. His work is supported by prominent supervisors including Prof. Michel van den Bekerom, Dr. Arthur van Noort, Dr. Bart van der Wal, and Prof. Jos Malda. Michał has contributed extensively to the scientific literature, publishing as first author on innovative orthopedic treatments and as co-author in high-impact journals, including The Lancet Respiratory Medicine, Journal of Shoulder and Elbow Surgery, and JSES Reviews, Reports & Techniques. His research has spanned topics from patient-specific bone regenerative implants and congenital hip dislocation management to COVID-19 respiratory subphenotypes and ventilation strategies. Michał’s professional development is complemented by diverse certifications and conferences, including Medical Device Regulation (EU MDR 2018), ISO 13485, 3D printing in hospitals, and arthroscopy and arthroplasty courses. Outside of his professional endeavors, he maintains an active lifestyle through kickboxing, Muay Thai, skiing, kite surfing, and cooking. His combination of scientific rigor, clinical expertise, and entrepreneurial initiative positions him as a rising leader in regenerative medicine and medical innovation.

Profile: Scopus

Featured Publications

van Spanning, S. H., van Iersel, T. P., Verweij, L. P. E., van Noort, A., Floor, S., Galek-Aldridge, M., van den Borne, M. P. J., Kleinlugtenbelt, Y. V., van den Bekerom, M. P. J., & van Deurzen, D. F. P. (2025). Lower education level is associated with failure to return to sport whereas bony Bankart lesions predict successful return to preinjury sport level after open Latarjet procedure. Arthroscopy: The Journal of Arthroscopic & Related Surgery. Advance online publication.

 

Muhammad Tahir Aleem | Health Sciences | Best Researcher Award

Published on by Research Awards

Dr. Muhammad Tahir Aleem | Health Sciences | Best Researcher Award 

Shantou University Medical College | China

Dr. Muhammad Tahir Aleem is a highly accomplished early-career scientist in the field of Preventive Veterinary Medicine and Molecular Parasitology, with a multidisciplinary research background spanning veterinary sciences, immunology, molecular biology, vaccine development, and zoonotic diseases. He holds a Doctor of Veterinary Medicine (DVM) and an M.Phil. in Parasitology from the University of Agriculture, Faisalabad, Pakistan, and earned his Ph.D. from Nanjing Agricultural University, China, where his doctoral research focused on the role of progesterone receptors in the reproduction of Trichinella spiralis, a key area in parasite biology. He completed two postdoctoral fellowships: one in Molecular Parasitology and Chromosome Biology at Cleveland State University, USA, and another in Basic Medicine at Shantou University Medical College, China. Dr. Aleem has authored over 15 peer-reviewed articles, including several in Q1 journals such as Vaccines, International Immunopharmacology, and Biomedical Research International, contributing to a cumulative impact factor exceeding 148.14. His studies delve into advanced vaccine design (mRNA, DNA), host-parasite interactions, immunomodulation, and molecular docking techniques, reflecting a strong command of both theoretical and applied biomedical sciences. He has served as corresponding author on multiple publications, highlighting his leadership in collaborative research. His work has garnered over 400 citations, with an estimated h-index of 8–10, showcasing his growing impact in the international scientific community. Dr. Aleem’s research has far-reaching implications for both veterinary and human health, especially in the control of parasitic diseases, emerging zoonoses, and infectious disease prevention. He actively collaborates across institutions and countries, demonstrating a global outlook and commitment to scientific innovation. His contributions to membrane-associated progesterone receptor studies have opened new avenues for reproductive parasitology, while his recent work on mRNA and DNA vaccine platforms marks him as a forward-looking investigator. He also contributes to public health and translational medicine by addressing environmental pathogens and drug development challenges. Given his high-impact publications, international collaborations, cross-disciplinary research profile, and growing citation footprint, Dr. Muhammad Tahir Aleem stands out as a promising and deserving candidate for the Best Researcher Award. His work not only advances veterinary and biomedical sciences but also paves the way for translational solutions to global health challenges.

Profiles: Scopus | Google Scholar

Featured Publications

COVIDSurg Collaborative, & GlobalSurg Collaborative. (2021). Timing of surgery following SARS‐CoV‐2 infection: An international prospective cohort study. Anaesthesia, 76(6), 748–758.

Sohail, M. U., Ijaz, A., Yousaf, M. S., Ashraf, K., Zaneb, H., Aleem, M., & Rehman, H. (2010). Alleviation of cyclic heat stress in broilers by dietary supplementation of mannan-oligosaccharide and Lactobacillus-based probiotic: Dynamics of cortisol, thyroid hormones and growth performance. Poultry Science, 89(9), 1934–1938.

Suleria, H. A. R., Butt, M. S., Khalid, N., Sultan, S., Raza, A., Aleem, M., & Abbas, M. (2015). Garlic (Allium sativum): Diet based therapy of 21st century – A review. Asian Pacific Journal of Tropical Disease, 5(4), 271–278.

Ijaz, A., Hussain, A., Aleem, M., Yousaf, M. S., & Rehman, H. (2009). Butylated hydroxytoluene inclusion in semen extender improves the post-thawed semen quality of Nili-Ravi buffalo (Bubalus bubalis). Theriogenology, 71(8), 1326–1329.

Sultan, S., Huma, N., Butt, M. S., Aleem, M., & Abbas, M. (2018). Therapeutic potential of dairy bioactive peptides: A contemporary perspective. Critical Reviews in Food Science and Nutrition, 58(1), 105–115.

Jamil, M., Aleem, M. T., Shaukat, A., Khan, A., Mohsin, M., Rehman, T. U., Abbas, R. Z., Saleemi, M. K., Khatoon, A., Babar, W., Yan, R., & Li, K. (2022). Medicinal plants as an alternative to control poultry parasitic diseases. Life, 12(3), 449.

Adeel, M., Ijaz, A., Aleem, M., Rehman, H., Yousaf, M. S., & Jabbar, M. A. (2009). Improvement of liquid and frozen-thawed semen quality of Nili-Ravi buffalo bulls (Bubalus bubalis) through supplementation of fat. Theriogenology, 71(8), 1220–1225.

COVIDSurg Collaborative, GlobalSurg Collaborative, Nepogodiev, D., et al. (2022). SARS‐CoV‐2 infection and venous thromboembolism after surgery: An international prospective cohort study. Anaesthesia, 77(1), 28–39.

Bajwa, H. U. R., Khan, M. K., Abbas, Z., Riaz, R., Rehman, T., Abbas, R. Z., Aleem, M. T., et al. (2022). Nanoparticles: Synthesis and their role as potential drug candidates for the treatment of parasitic diseases. Life, 12(5), 750.

Farooq, M., Durrani, F. R., Aleem, M., Chand, N., & Muqarrab, A. K. (2001). Egg traits and hatching performance of Desi, Fayumi and Rhode Island Red chicken. Pakistan Journal of Biological Sciences, 4(7), 909–911.

 

Cheng Ni | Health Sciences | Best Researcher Award | 13442

Published on by Research Awards

Prof. Cheng Ni | Health Sciences | Best Researcher Award

Prof. Cheng Ni, Cancer Hospital, Chinese Academy of Medical Sciences, China

Prof. Cheng Ni, M.D., Ph.D. is a Professor and Consultant Anesthesiologist at the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, where he also serves as Associate Chief of the Department of Anesthesiology. With extensive clinical and academic experience in thoracic anesthesiology, perioperative neuroprotection, and cancer pain management, Prof. Ni has held key roles at leading institutions including Peking University and Harvard University. His research focuses on perioperative neurocognitive disorders, tumor immunology, and the application of AI in anesthesiology. He has published over 50 SCI-indexed articles and holds 11 authorized patents.

Profile

Scopus

🎓 Early Academic Pursuits

Prof. Cheng Ni’s academic journey is a testament to dedication and intellectual rigor. He began his medical education at Capital Medical University, earning his M.D. in 2003 and M.S. in 2005, laying a solid foundation in medical sciences. His passion for deeper understanding and specialization led him to pursue a Ph.D. at Peking University, one of China’s most prestigious institutions, which he completed in 2012. This advanced academic training equipped him with a rich knowledge base in anesthesiology and related biomedical sciences, paving the way for a distinguished career in clinical practice, teaching, and research.

🩺 Professional Endeavors

Prof. Ni’s professional career reflects a steady and impactful rise through China’s top-tier medical institutions. He began as a Resident at Peking University Third Hospital (2005–2008) and subsequently served as an Attending Anesthesiologist (2008–2015). During this period, he gained hands-on clinical experience and honed his leadership abilities.

In 2013–2014, he expanded his global perspective as a Postdoctoral Research Fellow at Harvard University, engaging with cutting-edge international research. Upon his return, he held several key administrative and academic roles at Peking University, including Chief Secretary of the Faculty of Anesthesiology, and Associate Consultant and Associate Professor.

In 2020, Prof. Ni joined the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, a top national institution, as a Consultant and Associate Professor. His expertise quickly earned him leadership roles as Associate Chief of the Department of Anesthesiology, and by 2021, he was promoted to Professor and Consultant. He also became a Ph.D. Supervisor in 2023, mentoring the next generation of clinical researchers and specialists.

🔬 Contributions and Research Focus

Prof. Ni’s research contributions span multiple high-impact areas in modern anesthesiology and cancer care. His primary interests include:

  • Perioperative neurocognitive disorders 🧠

  • Thoracic anesthesiology and neuroprotection 💨🛡️

  • Cancer pain management 🧬

  • Genetics and tumor immunology 🧫

  • AI in anesthesiology research 🤖🩺

He has authored over 50 peer-reviewed articles in leading SCI-indexed journals, including Aging Cell, CNS Neuroscience & Therapeutics, Life Sciences, and Anesthesia & Analgesia. His recent publications explore the neuroinflammatory response during surgery, the effects of anesthesia on brain aging, and the integration of hybrid learning models for brain cell identification—blending medical science with artificial intelligence.

In addition to journal publications, Prof. Ni has contributed to 12 academic monographs and holds 11 authorized patents, underscoring his commitment to translational research and innovation.

🏅 Accolades and Recognition

Prof. Cheng Ni is widely respected in China’s medical and academic communities. His achievements have been recognized through his appointment to senior roles such as:

  • Chief Secretary of Anesthesiology Faculty, Peking University Health Science Center

  • Associate Chief of the Department of Anesthesiology at China’s National Cancer Center

  • Ph.D. Supervisor, guiding graduate-level research and fostering academic excellence

These appointments are not only acknowledgments of his skill and dedication but also affirmations of his influence in shaping anesthesiology and cancer care practices in China.

🌍 Impact and Influence

Prof. Ni’s work resonates far beyond the operating room. His integration of AI into anesthesiology research marks a forward-thinking approach to modern medicine. By exploring the cognitive effects of anesthesia, he contributes to improving surgical outcomes and patient safety, particularly in aging populations.

His leadership and mentorship roles at premier institutions like Peking University and the Cancer Hospital, CAMS, have helped nurture a generation of professionals equipped with both technical excellence and ethical insight.

Furthermore, his international collaboration with Harvard University has brought valuable cross-cultural research experience into Chinese clinical research settings, promoting a global standard in anesthesiology and perioperative medicine.

🌱 Legacy and Future Contributions

Looking ahead, Prof. Ni is poised to play a pivotal role in shaping the future of anesthesiology in cancer care. His continued emphasis on neuroprotection, chronic pain management, and artificial intelligence applications signals a progressive vision aligned with global health priorities.

As a Ph.D. supervisor and seasoned educator, his mentorship will continue to inspire emerging scholars. His innovations in clinical protocols and diagnostic tools will likely set new benchmarks in anesthetic safety and cancer patient recovery.

Prof. Cheng Ni stands as a bridge between tradition and innovation, combining deep clinical knowledge with research excellence to lead transformative change in anesthesiology and oncology care.

Publication Top Notes

Aged hippocampal single-cell atlas screening unveils disrupted neuroglial system in postoperative cognitive impairment

Author: Z., Suo, Zizheng, T., Xiao, Ting, Y., Qu, Yinyin, … H., Zheng, Hui, C., Ni, Cheng
Journal: Aging Cell
Year: 2025

Year: 2024